Literature DB >> 9163499

Validity of self-obtained vaginal specimens for diagnosis of trichomoniasis.

J R Schwebke1, S C Morgan, G B Pinson.   

Abstract

A comparison of self- and clinician-collected vaginal specimens for the diagnosis of trichomoniasis was conducted. The sensitivities of culture methods using self- and clinician-collected specimens were 84.6 and 88.5%, respectively. There was no significant difference between the sensitivities of culture methods using self- and clinician-collected vaginal specimens for the diagnosis of trichomoniasis.

Mesh：

Year:  1997        PMID： 9163499      PMCID： PMC229804          DOI： 10.1128/jcm.35.6.1618-1619.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  An evaluation of an InPouch TV culture method for diagnosing Trichomonas vaginalis infection.

Authors:  K A Borchardt; R F Smith
Journal:  Genitourin Med       Date:  1991-04

2.  Women's use of over-the-counter antifungal medications for gynecologic symptoms.

Authors:  D G Ferris; C Dekle; M S Litaker
Journal:  J Fam Pract       Date:  1996-06       Impact factor: 0.493

3.  Diagnosis of trichomoniasis. Comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens.

Authors:  J N Krieger; M R Tam; C E Stevens; I O Nielsen; J Hale; N B Kiviat; K K Holmes
Journal:  JAMA       Date:  1988-02-26       Impact factor: 56.272

4.  Clinical manifestations of vaginal trichomoniasis.

Authors:  P Wølner-Hanssen; J N Krieger; C E Stevens; N B Kiviat; L Koutsky; C Critchlow; T DeRouen; S Hillier; K K Holmes
Journal:  JAMA       Date:  1989-01-27       Impact factor: 56.272

5.  An innovative method for specimen autocollection in the diagnosis of vaginitis.

Authors:  R E Gwyther; L A Addison; S Spottswood; E J Bentz; S Evens; A Abrantes
Journal:  J Fam Pract       Date:  1986-11       Impact factor: 0.493

6.  Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study.

Authors:  M Laga; A Manoka; M Kivuvu; B Malele; M Tuliza; N Nzila; J Goeman; F Behets; V Batter; M Alary
Journal:  AIDS       Date:  1993-01       Impact factor: 4.177

7.  Self-administered vaginal swabs for population-based assessment of Trichomonas vaginalis prevalence.

Authors:  M J Wawer; D McNairn; F Wabwire-Mangen; L Paxton; R H Gray; N Kiwanuka
Journal:  Lancet       Date:  1995-01-14       Impact factor: 79.321

Review 8.  Urologic aspects of trichomoniasis.

Authors:  J N Krieger
Journal:  Invest Urol       Date:  1981-05

9.  Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations.

Authors:  R Amsel; P A Totten; C A Spiegel; K C Chen; D Eschenbach; K K Holmes
Journal:  Am J Med       Date:  1983-01       Impact factor: 4.965

10.  Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy.

Authors:  H Minkoff; A N Grunebaum; R H Schwarz; J Feldman; M Cummings; W Crombleholme; L Clark; G Pringle; W M McCormack
Journal:  Am J Obstet Gynecol       Date:  1984-12-15       Impact factor: 8.661
  10 in total
  20 in total

1.  Delayed versus immediate bedside inoculation of culture media for diagnosis of vaginal trichomonosis.

Authors:  J R Schwebke; M F Venglarik; S C Morgan
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  A prospective study of exposure to rap music videos and African American female adolescents' health.

Authors:  Gina M Wingood; Ralph J DiClemente; Jay M Bernhardt; Kathy Harrington; Susan L Davies; Alyssa Robillard; Edward W Hook
Journal:  Am J Public Health       Date:  2003-03       Impact factor: 9.308

3.  Risk and prevalence of treatable sexually transmitted diseases at a Birmingham substance abuse treatment facility.

Authors:  L H Bachmann; I Lewis; R Allen; J R Schwebke; L C Leviton; H A Siegal; E W Hook
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

4.  Value of consistent condom use: a study of sexually transmitted disease prevention among African American adolescent females.

Authors:  Richard A Crosby; Ralph J DiClemente; Gina M Wingood; Delia Lang; Kathy F Harrington
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

5.  Comparison of latex agglutination, wet preparation, and culture for the detection of Trichomonas vaginalis.

Authors:  Y Adu-Sarkodie; B K Opoku; K A Danso; H A Weiss; D Mabey
Journal:  Sex Transm Infect       Date:  2004-06       Impact factor: 3.519

6.  A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.

Authors:  Patricia Kissinger; Leandro Mena; Judy Levison; Rebecca A Clark; Megan Gatski; Harold Henderson; Norine Schmidt; Susan L Rosenthal; Leann Myers; David H Martin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12-15       Impact factor: 3.731

Review 7.  Trichomoniasis.

Authors:  Jane R Schwebke; Donald Burgess
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Adolescent women can perform a point-of-care test for trichomoniasis as accurately as clinicians.

Authors:  Jill S Huppert; Elizabeth Hesse; Grace Kim; Michael Kim; Patricia Agreda; Nicole Quinn; Charlotte Gaydos
Journal:  Sex Transm Infect       Date:  2010-06-30       Impact factor: 3.519

9.  From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections.

Authors:  Marcia M Hobbs; Barbara van der Pol; Patricia Totten; Charlotte A Gaydos; Anna Wald; Terri Warren; Rachel L Winer; Robert L Cook; Carolyn D Deal; M Elizabeth Rogers; Julius Schachter; King K Holmes; David H Martin
Journal:  Sex Transm Dis       Date:  2008-01       Impact factor: 2.830

Review 10.  Trichomonas vaginalis, HIV, and African-Americans.

Authors:  F Sorvillo; L Smith; P Kerndt; L Ash
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.